









Markets
/
Stocks
/
nasdaq-erna
/

Eterna Therapeutics Inc

ERNA

View Detailed Chart

1.560USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

81.51MMarket Cap

LossP/E TTM



Eterna Therapeutics Inc

1.560

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

-9.83%

5 Days

-20.00%

1 Month

-22.00%

6 Months

+331.42%

Year to Date

+430.61%

1 Year

-12.36%

View Detailed Chart

Agency Rating

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(4)

Neutral(2)

Buy(3)

Indicators

Sell(1)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.160

Neutral

RSI(14)

39.845

Neutral

STOCH(KDJ)(9,3,3)

6.814

Oversold

ATR(14)

0.215

High Vlolatility

CCI(14)

-200.763

Oversold

Williams %R

96.651

Oversold

TRIX(12,20)

0.307

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

1.768

Sell

MA10

1.907

Sell

MA20

1.928

Sell

MA50

1.523

Buy

MA100

0.869

Buy

MA200

0.700

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Eterna Therapeutics Inc. is a life science company committed to realizing the potential of messenger ribonucleic acid (RNA) (mRNA) cell engineering to provide patients with transformational new medicines. The Company has in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system (collectively mRNA technology platform). Its mRNA gene-editing technology is designed to delete, insert and repair deoxyribonucleic acid (DNA) sequences in living cells, which may be useful for correcting disease-causing mutations, making cells resistant to infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to more effectively fight cancer.

Ticker SymbolERNA

CompanyEterna Therapeutics Inc

CEOMr. Sanjeev Luther

Websitehttps://www.ernexatx.com/